Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
* [[Arzerra]] - Generic: Ofatumumab | * [[Arzerra]] - Generic: Ofatumumab | ||
* [[Rituxan]] - Generic: Rituximab | * [[Rituxan]] - Generic: Rituximab | ||
| + | =====Anti-melanoma [[Monoclonal Antibody]]===== | ||
| + | * [[Pembrolizumab]] - Generic: [[Keytruda]] | ||
=====B-Raf Kinase Inhibitor===== | =====B-Raf Kinase Inhibitor===== | ||
* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | * Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | ||
Revision as of 08:05, 21 January 2019
Anti-CD20 Monoclonal AntibodyAnti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
